15.71k followers • 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|The Fight Against COVID19||+0.38%||-||-||-|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|JNJ||Johnson & Johnson||148.73||+1.67||+1.14%||3:12 p.m. EDT||4.57M||6.03M||391.58B|
|PFE||Pfizer Inc.||36.6||+0.43||+1.19%||3:12 p.m. EDT||11.44M||26.80M||203.38B|
|ABBV||AbbVie Inc.||87.38||+0.49||+0.56%||3:12 p.m. EDT||5.11M||6.94M||154.21B|
|SNY||Sanofi||50.04||-0.46||-0.91%||3:12 p.m. EDT||687.18k||942.16k||125.29B|
|GSK||GlaxoSmithKline plc||37.62||+0.19||+0.51%||3:12 p.m. EDT||2.89M||2.91M||93.11B|
|GILD||Gilead Sciences, Inc.||63||+0.90||+1.45%||3:12 p.m. EDT||4.82M||8.68M||78.98B|
|REGN||Regeneron Pharmaceuticals, Inc.||559.888||-13.72||-2.39%||3:12 p.m. EDT||1.69M||716.23k||59.57B|
|TAK||Takeda Pharmaceutical Company Limited||17.855||-0.28||-1.57%||3:11 p.m. EDT||668.64k||1.02M||56.66B|
|MRNA||Moderna, Inc.||71.015||+0.50||+0.70%||3:12 p.m. EDT||12.63M||19.17M||28.02B|
|BNTX||BioNTech SE||68.13||+1.27||+1.90%||3:11 p.m. EDT||1.32M||3.56M||16.23B|
|NVAX||Novavax, Inc.||108.535||+0.59||+0.54%||3:12 p.m. EDT||3.86M||7.35M||6.65B|
|VIR||Vir Biotechnology, Inc.||34.12||-3.61||-9.57%||3:12 p.m. EDT||1.25M||1.18M||4.34B|
|INO||Inovio Pharmaceuticals, Inc.||11.64||+0.33||+2.92%||3:11 p.m. EDT||12.35M||27.25M||1.95B|
Dr. Roger Klein, Fmr. Adviser to the FDA & CDC joins Yahoo Finance’s Zack Guzman to discuss the latest coronavirus developments, as Moderna shares climb on positive vaccine news.
Quest Diagnostics has launched a 3-in-1 COVID-19 test that will work from a single swab. Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Anjalee Khemlani discuss the test, and the latest details in the race for a vaccine.
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. A group of genes passed down from extinct human cousins is linked with a higher risk for severe COVID-19, researchers say. When they compared the genetic profiles of about 3,200 hospitalized COVID-19 patients and nearly 900,000 people from the general population, they found that a cluster of genes on chromosome 3 inherited from Neanderthals who lived more than 50,000 years ago is linked with 60% higher odds of needing hospitalization.